Irish Journal of Medical Science, ISSN 0021-1265, 6/2013, Volume 182, Issue 2, pp. 297 - 300
Two processes of vastly different clinical characteristics—what we know today as “Aphthous Stomatitis” and “noma”—occupied the minds of dentists and doctors...
Stomatitis | Medicine & Public Health | History of medicine/modern | General Practice / Family Medicine | Internal Medicine | Noma/history | Aphthous/history | NOMA | MEDICINE, GENERAL & INTERNAL | ORIS | History, 17th Century | Diagnosis, Differential | Noma - diagnosis | Physicians | Humans | History, 16th Century | Infant | Stomatitis, Aphthous - history | History, 18th Century | Spain | Stomatitis, Aphthous - diagnosis | Noma - therapy | Stomatitis, Aphthous - therapy | Child | Dentists | Noma - history | Children | History | Ulcers | Diseases
Stomatitis | Medicine & Public Health | History of medicine/modern | General Practice / Family Medicine | Internal Medicine | Noma/history | Aphthous/history | NOMA | MEDICINE, GENERAL & INTERNAL | ORIS | History, 17th Century | Diagnosis, Differential | Noma - diagnosis | Physicians | Humans | History, 16th Century | Infant | Stomatitis, Aphthous - history | History, 18th Century | Spain | Stomatitis, Aphthous - diagnosis | Noma - therapy | Stomatitis, Aphthous - therapy | Child | Dentists | Noma - history | Children | History | Ulcers | Diseases
Journal Article
2.
Full Text
Increase of germ cell nuclear factor expression in globozoospermic Gopc−/− knockout mice
Andrology, ISSN 2047-2919, 05/2019, Volume 7, Issue 3, pp. 319 - 328
Background Golgi‐associated PDZ and coiled‐coil motif‐containing protein (GOPC) is a Golgi protein that plays a role in vesicular transport and intracellular...
GOPC | manchette | GCNF | Spermatogenesis | acrosome | COMPLEX | PROTEIN | ANDROLOGY | ORPHAN RECEPTOR | FACTOR GCNF/RTR | MALE-INFERTILITY | SPERM HEAD | LACKING | TESTIS | ACROSOME FORMATION
GOPC | manchette | GCNF | Spermatogenesis | acrosome | COMPLEX | PROTEIN | ANDROLOGY | ORPHAN RECEPTOR | FACTOR GCNF/RTR | MALE-INFERTILITY | SPERM HEAD | LACKING | TESTIS | ACROSOME FORMATION
Journal Article
Journal of Nutrition, ISSN 0022-3166, 12/2017, Volume 147, Issue 12, pp. 2272 - 2281
Background: Potatoes have a high glycemic load but also antioxidants, vitamins, and minerals. It is unclear what mechanisms are involved in relation to their...
Hypertension | PREDIMED study | Mediterranean | SUN cohort | Blood pressure | Potatoes | blood pressure | GLYCEMIC INDEX | potatoes | MEDITERRANEAN DIET | VALIDATION | RISK | ADHERENCE | PHYSICAL-ACTIVITY QUESTIONNAIRE | HEALTHY-ADULTS | OBESITY | NUTRITION & DIETETICS | GLUCOSE | CARDIOVASCULAR-DISEASE | hypertension | Blood Pressure | Diet - adverse effects | Solanum tuberosum | Humans | Middle Aged | Male | Hypertension - etiology | Spain - epidemiology | Aged, 80 and over | Adult | Female | Aged | Hypertension - epidemiology | Measurement | Diagnosis | Health aspects
Hypertension | PREDIMED study | Mediterranean | SUN cohort | Blood pressure | Potatoes | blood pressure | GLYCEMIC INDEX | potatoes | MEDITERRANEAN DIET | VALIDATION | RISK | ADHERENCE | PHYSICAL-ACTIVITY QUESTIONNAIRE | HEALTHY-ADULTS | OBESITY | NUTRITION & DIETETICS | GLUCOSE | CARDIOVASCULAR-DISEASE | hypertension | Blood Pressure | Diet - adverse effects | Solanum tuberosum | Humans | Middle Aged | Male | Hypertension - etiology | Spain - epidemiology | Aged, 80 and over | Adult | Female | Aged | Hypertension - epidemiology | Measurement | Diagnosis | Health aspects
Journal Article
Clinical and Translational Oncology, ISSN 1699-048X, 3/2017, Volume 19, Issue 3, pp. 279 - 287
Thyroid cancer is the single most prevalent endocrine malignancy; differentiated thyroid cancer (DTC) accounts for more than 90 % of all malignancies and its...
Thyroid cancer | Medicine & Public Health | Targeted therapy | Sorafenib | Oncology | Lenvatinib | Review | Differentiated thyroid cancer | Radioactive iodine-refractory thyroid cancer | ONCOLOGY | METASTASES | PAPILLARY | Cell Differentiation - radiation effects | Radiation Tolerance - drug effects | Iodine Radioisotopes | Thyroid Neoplasms - drug therapy | Cell Differentiation - drug effects | Practice Guidelines as Topic - standards | Protein Kinase Inhibitors - therapeutic use | Humans | Disease Management | Molecular Targeted Therapy | Consensus
Thyroid cancer | Medicine & Public Health | Targeted therapy | Sorafenib | Oncology | Lenvatinib | Review | Differentiated thyroid cancer | Radioactive iodine-refractory thyroid cancer | ONCOLOGY | METASTASES | PAPILLARY | Cell Differentiation - radiation effects | Radiation Tolerance - drug effects | Iodine Radioisotopes | Thyroid Neoplasms - drug therapy | Cell Differentiation - drug effects | Practice Guidelines as Topic - standards | Protein Kinase Inhibitors - therapeutic use | Humans | Disease Management | Molecular Targeted Therapy | Consensus
Journal Article
Journal of Dental Research, ISSN 0022-0345, 6/2010, Volume 89, Issue 6, pp. 571 - 574
Journal Article
Clinical and Translational Oncology, ISSN 1699-048X, 8/2016, Volume 18, Issue 8, pp. 769 - 775
Of all thyroid cancers, <5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays...
Carcinoembryonic antigen | Cabozantinib | Vandetanib | Thyroid cancer | Medicine & Public Health | Calcitonin | Oncology | Review | Medullary thyroid carcinoma | SURVIVAL | ASSOCIATION GUIDELINES | ZD6474 | HEREDITARY | ONCOLOGY | GROWTH | INHIBITOR | CELL | Thyroid Neoplasms - therapy | Carcinoma, Neuroendocrine - therapy | Carcinoma, Neuroendocrine - pathology | Humans | Thyroid Neoplasms - pathology
Carcinoembryonic antigen | Cabozantinib | Vandetanib | Thyroid cancer | Medicine & Public Health | Calcitonin | Oncology | Review | Medullary thyroid carcinoma | SURVIVAL | ASSOCIATION GUIDELINES | ZD6474 | HEREDITARY | ONCOLOGY | GROWTH | INHIBITOR | CELL | Thyroid Neoplasms - therapy | Carcinoma, Neuroendocrine - therapy | Carcinoma, Neuroendocrine - pathology | Humans | Thyroid Neoplasms - pathology
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2011, Volume 22, Issue 10, pp. 2343 - 2343
Journal Article
Journal of Dental Research, ISSN 0022-0345, 9/2009, Volume 88, Issue 9, pp. 777 - 780
Journal Article
Proceedings of the Nutrition Society, ISSN 0029-6651, 2013, Volume 72, Issue OCE1
Journal Article
Diabetes, ISSN 0012-1797, 05/1999, Volume 48, Issue 5, pp. 1108 - 1112
Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. J M Fernández-Real , A Molina , M Broch , W...
TNF RECEPTOR | CHOLESTEROL | ENDOTOXIN | ENDOCRINOLOGY & METABOLISM | MUSCLE | SENSITIVITY | HUMAN OBESITY | SOLUBLE RECEPTORS | EXPRESSION | FACTOR-ALPHA | ADIPOSE-TISSUE | Body Constitution | Body Mass Index | Tumor Necrosis Factor-alpha - metabolism | Glucose Tolerance Test | Fasting | Humans | Middle Aged | Insulin Resistance | Linear Models | Male | Insulin - blood | Myotonic Dystrophy - complications | Hyperlipidemias - etiology | Receptors, Tumor Necrosis Factor - blood | Triglycerides - blood | Adult | Cholesterol, LDL - blood | Female | Blood Glucose - metabolism | Diabetes | Research | Resistència a la insulina | Hyperlipidemia | Etiology | Necrosi | Insulin resistance | Hiperlipèmia | Metabolisme | Metabolism | Etiologia | Tumors | Necrosis
TNF RECEPTOR | CHOLESTEROL | ENDOTOXIN | ENDOCRINOLOGY & METABOLISM | MUSCLE | SENSITIVITY | HUMAN OBESITY | SOLUBLE RECEPTORS | EXPRESSION | FACTOR-ALPHA | ADIPOSE-TISSUE | Body Constitution | Body Mass Index | Tumor Necrosis Factor-alpha - metabolism | Glucose Tolerance Test | Fasting | Humans | Middle Aged | Insulin Resistance | Linear Models | Male | Insulin - blood | Myotonic Dystrophy - complications | Hyperlipidemias - etiology | Receptors, Tumor Necrosis Factor - blood | Triglycerides - blood | Adult | Cholesterol, LDL - blood | Female | Blood Glucose - metabolism | Diabetes | Research | Resistència a la insulina | Hyperlipidemia | Etiology | Necrosi | Insulin resistance | Hiperlipèmia | Metabolisme | Metabolism | Etiologia | Tumors | Necrosis
Journal Article
Nutricion hospitalaria, ISSN 0212-1611, 11/2004, Volume 19, Issue 6, p. 362
To determine the incidence of hypophosphatemia in parenterally fed patients, the phosphate amount necessary to prevent this complication and associated risks...
Hypophosphatemia - blood | Hypophosphatemia - etiology | Parenteral Nutrition - adverse effects | Blood Chemical Analysis | Hypophosphatemia - prevention & control | Humans | Middle Aged | Risk Factors | Calcium Phosphates - administration & dosage | Female | Male | Retrospective Studies
Hypophosphatemia - blood | Hypophosphatemia - etiology | Parenteral Nutrition - adverse effects | Blood Chemical Analysis | Hypophosphatemia - prevention & control | Humans | Middle Aged | Risk Factors | Calcium Phosphates - administration & dosage | Female | Male | Retrospective Studies
Journal Article
Nefrología, ISSN 0211-6995, 2017, Volume 37, Issue 37, pp. 253 - 266
The immunosuppressive combination most commonly used in de novo kidney transplantation comprises a calcineurin inhibitor (CI), tacrolimus, a mycophenolic acid...
Journal Article
Nefrología, ISSN 0211-6995, 2017, Volume 37, Issue 3, pp. 253 - 266
The immunosuppressive combination most commonly used in de novo kidney transplantation comprises a calcineurin inhibitor (CI), tacrolimus, a mycophenolic acid...
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 11/2018, Volume 27, Issue 11, pp. 831 - 837
Introduction: Thyrotoxicosis with hyperthyroidism is treated with these classical approaches (i) antithyroid drugs to blockade thyroid hormone release and...
thyroid receptor antagonists | antithyroid drugs | radioiodine | hyperthyroidism | Graves' disease | immunosuppressive treatment | thyrotoxicosis | thyroid stimulating hormone | Thyroid stimulating hormone receptor antagonist | Graves’ disease | DIAGNOSIS | DEXAMETHASONE | AMIODARONE | MANAGEMENT | HORMONE RECEPTOR ANTAGONISTS | TSH RECEPTOR | THERAPY | THYROTROPIN RECEPTOR | GRAVES-DISEASE | PHARMACOLOGY & PHARMACY | THYROID ASSOCIATION GUIDELINES | Glucocorticoids - therapeutic use | Drugs, Investigational - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Antithyroid Agents - therapeutic use | Drugs, Investigational - therapeutic use | Graves Disease - drug therapy | Hyperthyroidism - drug therapy | Hyperthyroidism - physiopathology | Thyrotoxicosis - drug therapy | Animals | Thyroid Hormones - metabolism | Drug Design | Graves Disease - physiopathology | Thyrotoxicosis - physiopathology | Antithyroid Agents - pharmacology
thyroid receptor antagonists | antithyroid drugs | radioiodine | hyperthyroidism | Graves' disease | immunosuppressive treatment | thyrotoxicosis | thyroid stimulating hormone | Thyroid stimulating hormone receptor antagonist | Graves’ disease | DIAGNOSIS | DEXAMETHASONE | AMIODARONE | MANAGEMENT | HORMONE RECEPTOR ANTAGONISTS | TSH RECEPTOR | THERAPY | THYROTROPIN RECEPTOR | GRAVES-DISEASE | PHARMACOLOGY & PHARMACY | THYROID ASSOCIATION GUIDELINES | Glucocorticoids - therapeutic use | Drugs, Investigational - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Antithyroid Agents - therapeutic use | Drugs, Investigational - therapeutic use | Graves Disease - drug therapy | Hyperthyroidism - drug therapy | Hyperthyroidism - physiopathology | Thyrotoxicosis - drug therapy | Animals | Thyroid Hormones - metabolism | Drug Design | Graves Disease - physiopathology | Thyrotoxicosis - physiopathology | Antithyroid Agents - pharmacology
Journal Article
15.
Full Text
Dietary inflammatory index and incidence of cardiovascular disease in the PREDIMED study
Nutrients, ISSN 2072-6643, 05/2015, Volume 7, Issue 6, pp. 4124 - 4138
Previous studies have reported an association between a more pro-inflammatory diet profile and various chronic metabolic diseases. The Dietary Inflammatory...
Cardiovascular disease | Inflammation | Dietary inflammatory index | PREDIMED | cardiovascular disease | RISK-FACTORS | MEDITERRANEAN DIET | MARKERS | ATHEROSCLEROSIS | PATTERNS | dietary inflammatory index | NUTRITION & DIETETICS | PLASMA | inflammation | COHORT | ASSOCIATION | Body Mass Index | Multivariate Analysis | Nuts | Prospective Studies | Diet, Mediterranean | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Treatment Outcome | Olive Oil | Energy Intake | Incidence | Endpoint Determination | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Surveys and Questionnaires | Aged | Cuina mediterrània | Malalties cardiovasculars | Mediterranean cooking | Health promotion | Inflamació | Cardiovascular diseases | Promoció de la salut
Cardiovascular disease | Inflammation | Dietary inflammatory index | PREDIMED | cardiovascular disease | RISK-FACTORS | MEDITERRANEAN DIET | MARKERS | ATHEROSCLEROSIS | PATTERNS | dietary inflammatory index | NUTRITION & DIETETICS | PLASMA | inflammation | COHORT | ASSOCIATION | Body Mass Index | Multivariate Analysis | Nuts | Prospective Studies | Diet, Mediterranean | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Treatment Outcome | Olive Oil | Energy Intake | Incidence | Endpoint Determination | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Surveys and Questionnaires | Aged | Cuina mediterrània | Malalties cardiovasculars | Mediterranean cooking | Health promotion | Inflamació | Cardiovascular diseases | Promoció de la salut
Journal Article
The Journal of Nutrition, ISSN 0022-3166, 11/2019, Volume 149, Issue 11, pp. 1920 - 1929
ABSTRACT Background Adherence to a Mediterranean diet (MedDiet) is thought to reduce liver steatosis. Objectives To explore the associations with liver...
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 11/2016, Volume 25, Issue 11, pp. 1345 - 1352
Introduction: Sunitinib is an oral oxindol derivative and a potent inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor...
sunitinib | open-label trials | randomized trials | Differentiated thyroid carcinoma | medullary thyroid carcinoma | tyrosine-kinase inhibitors | EFFICACY | FLK-1/KDR | SORAFENIB | SU11248 | IN-VIVO | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | VANDETANIB | GROWTH-FACTOR | CARCINOMA | Carcinoma, Neuroendocrine - drug therapy | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Agents - therapeutic use | Disease-Free Survival | Pyrroles - pharmacology | Animals | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Protein Kinase Inhibitors - therapeutic use | Angiogenesis Inhibitors - therapeutic use | Indoles - pharmacology | Indoles - therapeutic use | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Pyrroles - therapeutic use | Thyroid Neoplasms - pathology
sunitinib | open-label trials | randomized trials | Differentiated thyroid carcinoma | medullary thyroid carcinoma | tyrosine-kinase inhibitors | EFFICACY | FLK-1/KDR | SORAFENIB | SU11248 | IN-VIVO | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | VANDETANIB | GROWTH-FACTOR | CARCINOMA | Carcinoma, Neuroendocrine - drug therapy | Humans | Angiogenesis Inhibitors - pharmacology | Antineoplastic Agents - therapeutic use | Disease-Free Survival | Pyrroles - pharmacology | Animals | Thyroid Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Protein Kinase Inhibitors - therapeutic use | Angiogenesis Inhibitors - therapeutic use | Indoles - pharmacology | Indoles - therapeutic use | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Pyrroles - therapeutic use | Thyroid Neoplasms - pathology
Journal Article